-
Je něco špatně v tomto záznamu ?
2-Deoxyglycoside Conjugates of Lupane Triterpenoids with High Cytotoxic Activity-Synthesis, Activity, and Pharmacokinetic Profile
P. Perlikova, M. Kvasnica, M. Urban, M. Hajduch, J. Sarek,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
31553559
DOI
10.1021/acs.bioconjchem.9b00565
Knihovny.cz E-zdroje
- MeSH
- antitumorózní látky chemie farmakologie MeSH
- deoxycukry chemie MeSH
- glykosidy chemie MeSH
- léky antitumorózní - screeningové testy MeSH
- lidé MeSH
- myši MeSH
- nádorové buňky kultivované MeSH
- nádory farmakoterapie metabolismus patologie MeSH
- proliferace buněk * MeSH
- tkáňová distribuce MeSH
- triterpeny chemie farmakokinetika farmakologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A set of 41 glycosidic conjugates of pentacyclic triterpenes was synthesized in order to improve the solubility of highly cytotoxic parent compounds. Their in vitro cytotoxic activity was evaluated in 25 cancer cell lines and 2 noncancer fibroblasts. Fifteen compounds had high cytotoxicity on the T-lymphoblastic leukemia cell line CCRF-CEM and 6 of them were active in multiple cell lines of various histogenic origin and not toxic in fibroblasts. Compound 11a had IC50 of 0.64 μM in CCRF-CEM cells, 0.60 μM in K-562 cells, and 0.37 μM in PC-3 cells; compound 12a had IC50 of 0.64 μM in CCRF-CEM cells and 0.71 μM in SW620 cells; compound 17b had IC50 of 0.86 μM in HCT116 cells and 0.92 μM in PC-3 cells. Compounds 11b and 12b were slightly less active than the previously mentioned derivatives; however, their solubility was significantly better, and therefore they were selected for the in vivo evaluation of the pharmacokinetic profile in mice. In both compounds, the maximum concentration in plasma was achieved very rapidly-the highest level in plasma was found 1 h after administration (22.2, respectively, 6.4 μM). For compound 12b, the resorption was followed with fast elimination, and 12 h after administration, the compound was not detected in plasma. In contrast, compound 11b was eliminated more slowly; it was still present in plasma after 12 h, but its concentration dropped below the detection limit after 24 h. The elimination half-time determined for compound 11b was 2.4 h and for compound 12b just about 1.4 h. These values are reasonable for further drug development.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025487
- 003
- CZ-PrNML
- 005
- 20201222155225.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.bioconjchem.9b00565 $2 doi
- 035 __
- $a (PubMed)31553559
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Perlikova, Pavla $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo n. 2 , 16610 Prague 6, Czech Republic.
- 245 10
- $a 2-Deoxyglycoside Conjugates of Lupane Triterpenoids with High Cytotoxic Activity-Synthesis, Activity, and Pharmacokinetic Profile / $c P. Perlikova, M. Kvasnica, M. Urban, M. Hajduch, J. Sarek,
- 520 9_
- $a A set of 41 glycosidic conjugates of pentacyclic triterpenes was synthesized in order to improve the solubility of highly cytotoxic parent compounds. Their in vitro cytotoxic activity was evaluated in 25 cancer cell lines and 2 noncancer fibroblasts. Fifteen compounds had high cytotoxicity on the T-lymphoblastic leukemia cell line CCRF-CEM and 6 of them were active in multiple cell lines of various histogenic origin and not toxic in fibroblasts. Compound 11a had IC50 of 0.64 μM in CCRF-CEM cells, 0.60 μM in K-562 cells, and 0.37 μM in PC-3 cells; compound 12a had IC50 of 0.64 μM in CCRF-CEM cells and 0.71 μM in SW620 cells; compound 17b had IC50 of 0.86 μM in HCT116 cells and 0.92 μM in PC-3 cells. Compounds 11b and 12b were slightly less active than the previously mentioned derivatives; however, their solubility was significantly better, and therefore they were selected for the in vivo evaluation of the pharmacokinetic profile in mice. In both compounds, the maximum concentration in plasma was achieved very rapidly-the highest level in plasma was found 1 h after administration (22.2, respectively, 6.4 μM). For compound 12b, the resorption was followed with fast elimination, and 12 h after administration, the compound was not detected in plasma. In contrast, compound 11b was eliminated more slowly; it was still present in plasma after 12 h, but its concentration dropped below the detection limit after 24 h. The elimination half-time determined for compound 11b was 2.4 h and for compound 12b just about 1.4 h. These values are reasonable for further drug development.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antitumorózní látky $x chemie $x farmakologie $7 D000970
- 650 12
- $a proliferace buněk $7 D049109
- 650 _2
- $a deoxycukry $x chemie $7 D003837
- 650 _2
- $a léky antitumorózní - screeningové testy $7 D004354
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykosidy $x chemie $7 D006027
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a nádory $x farmakoterapie $x metabolismus $x patologie $7 D009369
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 _2
- $a triterpeny $x chemie $x farmakokinetika $x farmakologie $7 D014315
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kvasnica, Miroslav $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research , Institute of Experimental Botany of the Czech Academy of Sciences and Palacky University , Šlechtitelů 27 , 78371 Olomouc , Czech Republic.
- 700 1_
- $a Urban, Milan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry , Palacky University , Hnevotinská 5 , 77900 , Olomouc , Czech Republic.
- 700 1_
- $a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry , Palacky University , Hnevotinská 5 , 77900 , Olomouc , Czech Republic.
- 700 1_
- $a Sarek, Jan $u Betulinines , Sazavska 323 , 28167 Stribrna Skalice , Czech Republic.
- 773 0_
- $w MED00006454 $t Bioconjugate chemistry $x 1520-4812 $g Roč. 30, č. 11 (2019), s. 2844-2858
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31553559 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155221 $b ABA008
- 999 __
- $a ok $b bmc $g 1599632 $s 1116173
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 30 $c 11 $d 2844-2858 $e 20191008 $i 1520-4812 $m Bioconjugate chemistry $n Bioconjug Chem $x MED00006454
- LZP __
- $a Pubmed-20201125